ES2160093B1 - Derivados del acido p-hidroxifenil propionico como agentes antiproliferativos. - Google Patents

Derivados del acido p-hidroxifenil propionico como agentes antiproliferativos.

Info

Publication number
ES2160093B1
ES2160093B1 ES200000660A ES200000660A ES2160093B1 ES 2160093 B1 ES2160093 B1 ES 2160093B1 ES 200000660 A ES200000660 A ES 200000660A ES 200000660 A ES200000660 A ES 200000660A ES 2160093 B1 ES2160093 B1 ES 2160093B1
Authority
ES
Spain
Prior art keywords
derivatives
antiproliferative agents
acid
hydroxifenil
propionic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200000660A
Other languages
English (en)
Other versions
ES2160093A1 (es
Inventor
Barrera Jaime Bermejo
Silva Margarita Hernandez
De Mon Melchor Alvarez
Ranieri Juan Pablo Pivel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INVESTIG Y MEDICINA SL
SAETABIS BIO CONSULTING
Consejo Superior de Investigaciones Cientificas CSIC
Original Assignee
INVESTIG Y MEDICINA SL
SAETABIS BIO CONSULTING
Consejo Superior de Investigaciones Cientificas CSIC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES200000660A priority Critical patent/ES2160093B1/es
Application filed by INVESTIG Y MEDICINA SL, SAETABIS BIO CONSULTING, Consejo Superior de Investigaciones Cientificas CSIC filed Critical INVESTIG Y MEDICINA SL
Priority to EP01911771A priority patent/EP1284263B1/en
Priority to AU2001240702A priority patent/AU2001240702A1/en
Priority to PCT/ES2001/000102 priority patent/WO2001072733A1/es
Priority to DE60101472T priority patent/DE60101472T2/de
Priority to ES01911771T priority patent/ES2213106T3/es
Publication of ES2160093A1 publication Critical patent/ES2160093A1/es
Application granted granted Critical
Publication of ES2160093B1 publication Critical patent/ES2160093B1/es
Priority to US10/251,914 priority patent/US6818780B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58—One oxygen atom, e.g. butenolide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Derivados del ácido p-hidroxifenil propiónico como agentes antiproliferativos. Derivados del compuesto ácido por p- hidroxifenil propiónico caracterizados por tener dichos derivados las formulas generales (I) y (Ia), donde n puede tomar los valores 1,2,3; R puede ser H ó CH{sub,3} y R{sub,1}, puede ser CH{sub,3} ó H con actividad farmacológica y su aplicación en medicina para el tratamiento de desórdenes del sistema inmunológico.
ES200000660A 2000-03-20 2000-03-20 Derivados del acido p-hidroxifenil propionico como agentes antiproliferativos. Expired - Fee Related ES2160093B1 (es)

Priority Applications (7)

Application Number Priority Date Filing Date Title
ES200000660A ES2160093B1 (es) 2000-03-20 2000-03-20 Derivados del acido p-hidroxifenil propionico como agentes antiproliferativos.
AU2001240702A AU2001240702A1 (en) 2000-03-20 2001-03-16 Derivatives of p- hydroxy phenyl propionic acid as antiproliferative agents
PCT/ES2001/000102 WO2001072733A1 (es) 2000-03-20 2001-03-16 Derivados del acido p-hidroxifenil propionico como agentes antiproliferativos
DE60101472T DE60101472T2 (de) 2000-03-20 2001-03-16 Derivate von p-hydroxyphenyl-propionsäure als antiproliferative mittel
EP01911771A EP1284263B1 (en) 2000-03-20 2001-03-16 Derivatives of p- hydroxy phenyl propionic acid as antiproliferative agents
ES01911771T ES2213106T3 (es) 2000-03-20 2001-03-16 Derivados del acido p-hidroxifenil propionico como agentes antiproliferativos.
US10/251,914 US6818780B2 (en) 2000-03-20 2002-09-20 P-hydroxyphenyl propionic acid derivatives as antiproliferative agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200000660A ES2160093B1 (es) 2000-03-20 2000-03-20 Derivados del acido p-hidroxifenil propionico como agentes antiproliferativos.

Publications (2)

Publication Number Publication Date
ES2160093A1 ES2160093A1 (es) 2001-10-16
ES2160093B1 true ES2160093B1 (es) 2002-06-16

Family

ID=8492770

Family Applications (2)

Application Number Title Priority Date Filing Date
ES200000660A Expired - Fee Related ES2160093B1 (es) 2000-03-20 2000-03-20 Derivados del acido p-hidroxifenil propionico como agentes antiproliferativos.
ES01911771T Expired - Lifetime ES2213106T3 (es) 2000-03-20 2001-03-16 Derivados del acido p-hidroxifenil propionico como agentes antiproliferativos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES01911771T Expired - Lifetime ES2213106T3 (es) 2000-03-20 2001-03-16 Derivados del acido p-hidroxifenil propionico como agentes antiproliferativos.

Country Status (6)

Country Link
US (1) US6818780B2 (es)
EP (1) EP1284263B1 (es)
AU (1) AU2001240702A1 (es)
DE (1) DE60101472T2 (es)
ES (2) ES2160093B1 (es)
WO (1) WO2001072733A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2070533B1 (en) * 2007-12-11 2014-05-07 Apoteknos Para La Piel, s.l. Use of a compound derived from P-hydroxyphenyl propionic acid for the treatment of psoriasis
ES2379925B1 (es) * 2010-10-06 2013-03-19 Apoteknos Para La Piel, S.L. PROCEDIMIENTO PARA LA SINTESIS DE LACTONAS DERIVADAS DEL ACIDO p-HIDROXIFENIL PROPIONICO
ES2388965B1 (es) * 2011-03-24 2013-09-05 Apoteknos Para La Piel S L PROCEDIMIENTO PARA LA SINTESIS DE LACTONAS DERIVADAS DEL ACIDO p-HIDROXIFENIL PROPIONICO MEJORADO.
CN102212007A (zh) * 2011-04-11 2011-10-12 启东东岳药业有限公司 高纯度2-羟甲基丙烯酸甲酯的制备方法

Also Published As

Publication number Publication date
DE60101472D1 (en) 2004-01-22
ES2160093A1 (es) 2001-10-16
WO2001072733A1 (es) 2001-10-04
ES2213106T3 (es) 2004-08-16
US20030199575A1 (en) 2003-10-23
US6818780B2 (en) 2004-11-16
AU2001240702A1 (en) 2001-10-08
DE60101472T2 (de) 2004-10-07
EP1284263A1 (en) 2003-02-19
EP1284263B1 (en) 2003-12-10

Similar Documents

Publication Publication Date Title
DE50010931D1 (de) Substituierte benzimidazole
ES2159851T3 (es) Amidas de acidos aminotiofenocarboxilicos y su empleo como inhibidores de la fosfodiestearasa.
GB0305929D0 (en) Organic compounds
ES2081936T3 (es) Composiciones anfoteras y formas polimericas de alfa-hidroxiacidos, y su uso terapeutico.
NO20050807L (no) Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser
ES2086623T3 (es) Azaheterociclilmetil-cromanos como principios activos para el tratamiento de enfermedades del sistema nervioso central.
ES2154266T3 (es) Amidas de acido sulfonamidocarbonilpiridin-2-carboxilico y su empleo como medicamentos.
DK1485080T3 (da) Anvendelse af adapalen til behandling af dermatologiske sygdomme
ES2113881T3 (es) Derivados y analogos de acido 2-desoxi-2,3-didehidro-n-acetil neuraminico y su utilizacion como agentes antivirales.
PA8491001A1 (es) Inhibidores de la recaptacion de monoaminas para el tratamiento de trastornos del snc.
ES2102367T3 (es) Amidas de acidos isoxazol-4-carboxilicos y amidas de acidos hidroxialquiliden-cianoaceticos, medicamentos que contienen estos compuestos y su utilizacion.
DE69905368T2 (de) Oxydiertes thymosin beta 4
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
CY1107312T1 (el) Θειικη 3,5,3’-τριιωδοθυρονινη σαν θυρεοειδο-μιμητικος παραγοντας και φαρμακευτικα σκευασματα της
AR028705A1 (es) Bis-arilsulfonas
ES2089687T3 (es) 4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa.
AR024380A1 (es) Tienopirimidinas
EA200200742A1 (ru) 1,2-диарилбензимидазолы для лечения заболеваний, связанных с активацией микроглии
TR200400228T4 (tr) Psöryazinin tedavisinde kullanılacak maddeler
AR025569A1 (es) Pirazol [4,3-d] pirimidinas
ATE413399T1 (de) Morpholinyl-harnstoff-derivative fuer die behandlung von krankheiten verbunden mit entzuendlichen prozessen
ES2160093B1 (es) Derivados del acido p-hidroxifenil propionico como agentes antiproliferativos.
ATE133680T1 (de) Oligosaccharidderivate und deren verwendung in heilmitteln
ES2124861T3 (es) Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.
ES2087407T3 (es) Derivados de cromano sustituido con piperidilmetilo como principio activo para el tratamiento de enfermedades del sistema nervioso central.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20011016

Kind code of ref document: A1

Effective date: 20011016

FD1A Patent lapsed

Effective date: 20050321